Accord Healthcare Announces Launch of Denosumab – Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification…
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
November 28, 2025 20:13 ET Â | Source: Rakovina Therapeutics Inc VANCOUVER, British…
